Introduction & Objective: Nigeria is one of the developing countries with a major burden of non-communicable diseases (NCDs) without disease self-management programme in its healthcare system. This study aimed to determine the baseline self-efficacy levels of Nigerian patients with chronic NCDs.

Methods: This is a cross-sectional study of patients with NCDs attending tertiary level clinics with full compliments of NCD healthcare professionals. Patients were interviewed on ten-Self-Efficacy questionnaires to Manage Chronic Disease (SEMCD) item scales that were appropriate for the Nigerian population. The patients were assessed under: (i) exercise regularly, (ii) help from community, family and friends, (iii) communication with physician, (iv) manage disease and (v) manage symptom self-efficacy domains. Data were analysed both descriptively and statistically using the SPSS software.

Results: The results showed that more females (59.4%) than males (40.6%) attended clinics during the 3 months study period, and the mean age of the patients did not differ between gender (p>0.05). About 40% of all the patients manage their NCDs with medications alone, a trend that is similar in male and female patients (p>0.05). While all the patients had a relatively lower self-efficacy scores under regular exercise scale (52-55%) and manage disease symptoms scale (53-55%), they tended towards higher self-efficacy scores under getting assistance from community, family, and friends (79-80%) and communication with attending physicians (81-85%).

Conclusion: Nigeria patients with NCDs at tertiary level institution clinics are less than optimal in disease self-management care. The observed sub-optimal self-efficacy levels might be a contributing factor to high premature NCD deaths in this population. It is recommended that this study population will benefit from introduction and implementation of disease self-management programme in the healthcare system.

Disclosure

C.E. Ezenwaka: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.